Cullinan Therapeutics, Inc. employees and revenue per employee

CGEM · Biotechnology · $954M market cap

Cullinan Therapeutics, Inc. had 31 employees at the end of fiscal Dec 2021. Revenue for the year was $18.9M, or $611K per employee.

The latest annual report we hold is more than two years old, so these numbers may be out of date.

Employees

31

Revenue

$18.9M

Revenue / employee

$611K

Peer median $459K

Rank in industry

47 of 109

Biotechnology

Headcount against revenue

Both lines start at 100 in the first year we hold, so you can see which one grew faster.

Only one fiscal year on file so far, so there is no trend to draw yet.

Employees, last six fiscal years
31'21
Revenue per employee, last six fiscal years
$611K'21

Cullinan Therapeutics, Inc. against similar companies

The closest industry peers by revenue, from Biotechnology.

CompanyEmployeesRevenueRevenue / employeeShape
CGEM
Cullinan Therapeutics, Inc.
31$18.9M$611K—
OBIO
Orchestra BioMed Holdings, Inc.
86$33.5M$389KEfficient growth
VSTM
Verastem, Inc.
102$30.9M$303KEfficient growth
CBIO
Crescent Biopharma, Inc.
44$10.8M$246K—
CAPR
Capricor Therapeutics, Inc.
160$22.3M$139KHiring into decline
ALMS
Alumis Inc.
221$24.1M$109K—
JANX
Janux Therapeutics, Inc.
109$10.0M$92KHiring into decline
RLAY
Relay Therapeutics, Inc.
192$15.4M$80KLeaner
ZBIO
Zenas BioPharma, Inc.
167$10.0M$60KEfficient growth
Every Healthcare company

Questions about Cullinan Therapeutics, Inc.

How many employees does Cullinan Therapeutics, Inc. have?
Cullinan Therapeutics, Inc. reported 31 employees for the fiscal year ending Dec 2021, in the annual report it filed on March 17, 2022.
What is Cullinan Therapeutics, Inc.'s revenue per employee?
Cullinan Therapeutics, Inc. brought in $18.9M of revenue in fiscal Dec 2021, which is $611K per employee. That ranks 47 of 109 companies we track in Biotechnology, where the median is $459K.
Where do these numbers come from?
Employee counts and revenue are taken from each company's own annual report (Form 10-K). Open roles are counted from the company's public job board where we have matched one. Companies report headcount once a year, sometimes rounded, so small changes can be noise.

Think you can pick better than the S&P 500?

Pick 15 stocks, lock them in, and we score them against the index every trading day for ten years. Free, with a public leaderboard.

Enter the challenge

Compare CGEM with the rest of the market

See who earns the most per employee, who is hiring, and who is cutting, across every company we track.

Source: employee counts and revenue as stated in Cullinan Therapeutics, Inc.'s annual reports (Form 10-K), latest filed March 17, 2022. This is data, not a recommendation to buy or sell CGEM.